| Variables | Neoadjuvant Chemotherapy [n - 16] | Primary Cytoreductive surgery [n- 28] | P value |
| 1. Estimated blood loss, mean (SD), ml | 946.9 (747.1) | 790 (611.9) | 0.477 |
| 2. Intraoperative complications | |||
| Blood loss > 2000 ml | 3(18.8%) | 2(07.1%) | 0.243 |
| Visceral injury (Urinary tract) | 1(06.3%) | 1(03.5%) | |
| Visceral injury (Bowel) | 0 | 1(03.5%) | |
| 3. Duration of hospital stay (mean), days | 5.63 | 5.61 | 0.977 |
| 4. Intraoperative complications | |||
| Urosepsis | 1(06.3%) | 0 | |
| AKI | 1(06.3%) | 0 | |
| Readmission | 0 | 0 | |
| Mortality | 0 | 0 | |
| 5. Debulking status | |||
| Suboptimal (> 1 cm) | 5(31.2%) | 11(39.3%) | 0.547 |
| Optimal ( | 3(18.8%) | 2(07.1%) | |
| No gross residual | 8(50.0%) | 15(53.6%) | |